Fundamental Analysis of TherapeuticsMD Inc - Growth / Value Index
TXMD - Valuation Highlights
Valuation Analysis
Tsr Value Index - Poor Score of 28.12
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | -3.75 | 0.339 | 82.78 % | |
| Price to Book | 1.07 | 0.791 | 33.77 % | 0.893 |
| Price to Sales | 21.59 | 0.334 | 12.44 % | |
| Enterprise Value to EBITDA Multiple | -4.67 | 0.295 | 139.61 % |
TXMD - Profitability Highlights
Profitability Analysis
Piotroski F Score - Stable Value of 5.0
EBITDA is continuously increasing for last 3 Years
Tsr Profitability Index - Very Poor Score of 5.00
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | -28.47 | 233.23 | -26.81 % | -2.56 |
| Return On Asset | -18.12 | 157.72 | 27.39 % | -1.74 |
| Net Profit Margin | -576.11 | 98.47 | -38.49 % | -234.50 |
| Operating Profit Margin | -521.66 | 73.53 | 155.48 % | -364.86 |
| EBITDA Margin | -562.47 | 99.33 | 225.83 % | -215.97 |
Highlights
| Market Cap | 25601.93 K |
| Enterprise Value | 22747.93 K |
| Price/Book TTM | 1.07 |
| Outstanding Share | 11532.40 K |
| Float/ Outstanding Share | 85.95% |
| Dividend Yield | 1.33 % |
Share Holding
Guru Numbers
| Price/Graham No | 0 |
| Peter Lynch Ratio | 12.08 |
| Piotroski F Score | 5.00 |
| Altman Z Score | -22.82 |
| Sloan Ratio | 1.61 |
| Peter Lynch Fair Value | 0 |
TXMD - Growth Highlights
Growth Analysis
Tsr Growth Index - Good Score of 65.62
Company's Total Assets is Decreasing for last 3 years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 865108 | 0.853 % | 37.65 % |
| Gross Profit | 65373.00 | 1.17 % | 233.33 % |
| EBITDA | -4865.95 K | 223.05 % | 30.60 % |
| Net Profit | -4983.95 K | 39.01 % | 16.87 % |
| EPS | -0.592 | 45.29 % | NA |
TXMD - Stability Highlights
Stability Analysis
Tsr Stability Index - Good Score of 75.00
Altman Z Score of -22.91 suggest high risk
Company is unable to generate enough free cash to support the business.
Interest Coverage of 0
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.050 | 27.16 % | 0.052 |
| Cash Ratio | 0.631 | -22.32 % | |
| Quick Ratio | 0 | 0 % | 1.78 |
| Shareholders Equity | 67.62 | 74.06 % | |
| Debt to EBITDA | 0.0214 | -67.20 % |
Historical Valuation Ratios of TherapeuticsMD Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of TherapeuticsMD Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of TherapeuticsMD Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of TherapeuticsMD Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)